$69 postpage LB

What are biosimilars?

  • November 18, 2020 09:04 PM AEDT
  • Team Kalkine

A biosimilar drug is a biological formulation developed in a way similar to an already-approved biologic, also known as the reference product. Biologics offer relatively cheaper treatment alternatives for patients suffering from chronic and often disabling indications like autoimmune disease, diabetes, and cancers. While one might think that biosimilars are akin to generic drugs, there are significant differences between the two. Generics are chemically identical to the branded drugs. However, a biosimilar is not a replica of another biological product. There is a level of natural variability in all biological products, and it is not possible to make an exact copy of a product that comes from living cells. All biologic, including reference products, indicate a few variations in batch-to-batch formulations.

Gold MTF non-AMP

* How are Biosimilars Regulated?

In the US, a regulatory pathway for approval of biosimilars was made possible by the BCPI act or Biologics Price Competition & Innovation Act. This act is a provision comprised in the Patient Protection and Affordable Care Act of 2010. The Food and Drug Administration (FDA) gauges the safety as well as the efficacy of all the new, original biologics. Evaluation of biologics is the same as for new conventional medications. The purpose of developing a biosimilar is to determine that the proposed biosimilar is highly comparable to the reference product, with similar safety and efficacy.

 


Disclaimer
The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.

 

   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK